# Phase 2 asthma trials recruiting: 38 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 38 trials in phase 2 for asthma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 asthma trials: 38 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/asthma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 38
- Recruiting or not yet: 38
- Read on: November 19, 2026

## Trials

The 25 newest of 38, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 28, 2026 | NCT07792395 | Ginger's Therapeutic Potential in Asthma | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Asthma | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07792395) |
| August 5, 2026 | NCT07746687 | A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma | Janssen Research & Development, LLC | Phase 2 | Recruiting | Asthma | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746687) |
| July 27, 2026 | NCT07728851 | Nebulized Ketamine for Severe Asthma Attacks in Children | Sultan Qaboos University | Phase 2 | Not yet recruiting | Asthma Acute, Exacerbation of Allergic Asthma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728851) |
| July 15, 2026 | NCT07705737 | Rademikibart IV for Acute Asthma and COPD Exacerbation | Connect Biopharm LLC | Phase 2 | Recruiting | Asthma Acute, COPD Exacerbation Acute | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705737) |
| June 30, 2026 | NCT07677059 | A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study | Kymera Therapeutics, Inc. | Phase 2 | Recruiting | Asthma (Diagnosis) | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07677059) |
| May 15, 2026 | NCT07589439 | Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma | Shanghai Novamab Biopharmaceuticals Co., Ltd. | Phase 2 | Recruiting | Asthma | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589439) |
| April 15, 2026 | NCT07532265 | A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma | Kinaset Therapeutics Inc | Phase 2 | Recruiting | Severe Asthma | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07532265) |
| April 13, 2026 | NCT07525375 | A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in... | AstraZeneca | Phase 2 | Recruiting | Asthma | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07525375) |
| March 30, 2026 | NCT07500974 | Efficacy of L-menthol on Breathlessness in Asthma | Region Skane | Phase 2 | Recruiting | Asthma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07500974) |
| March 6, 2026 | NCT07455396 | Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical... | Johns Hopkins All Children's Hospital | Phase 2 | Recruiting | Asthma (Diagnosis) | 159 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07455396) |
| February 27, 2026 | NCT07436221 | A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma | Akeso | Phase 2 | Not yet recruiting | Asthma | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07436221) |
| January 8, 2026 | NCT07326995 | Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma | Anhui Palo Alto Pharmaceuticals, Inc. | Phase 2 | Recruiting | Bronchial Asthma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07326995) |
| January 7, 2026 | NCT07324707 | Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma | Anhui Palo Alto Pharmaceuticals, Inc. | Phase 2 | Recruiting | Bronchial Asthma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07324707) |
| December 24, 2025 | NCT07301736 | Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma | Chiesi Farmaceutici S.p.A. | Phase 2 | Recruiting | Asthma | 780 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301736) |
| December 24, 2025 | NCT07301255 | ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults | Enveda Therapeutics | Phase 2 | Recruiting | Asthma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301255) |
| December 15, 2025 | NCT07282886 | VENTURI (VENTilation Using Respiratory Imaging) | University of Alabama at Birmingham | Phase 2 | Recruiting | Asthma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07282886) |
| November 21, 2025 | NCT07241546 | Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma | Arrowhead Pharmaceuticals | Phase 2 | Recruiting | Asthma | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07241546) |
| October 21, 2025 | NCT07219173 | A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma | Eli Lilly and Company | Phase 2 | Recruiting | Asthma | 531 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07219173) |
| September 25, 2025 | NCT07191535 | Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) | Foresee Pharmaceuticals Co., Ltd. | Phase 2 | Not yet recruiting | Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07191535) |
| September 18, 2025 | NCT07179952 | Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) | Indiana University | Phase 2 | Not yet recruiting | Asthma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07179952) |
| August 13, 2025 | NCT07120503 | Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma | Sponsor not shown (see the record) | Phase 2 | Recruiting | Asthma | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07120503) |
| August 8, 2025 | NCT07112456 | Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations | Oman Medical Speciality Board | Phase 2 | Recruiting | Asthma Acute, Asthma Attack, Asthma Exacerbations | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07112456) |
| June 8, 2025 | NCT07011524 | Study of CM512 Injection in Subjects With Moderate-to-severe Asthma | Keymed Biosciences Co.Ltd | Phase 2 | Recruiting | Asthma | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07011524) |
| May 18, 2025 | NCT06977581 | A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma | Pfizer | Phase 2 | Recruiting | Asthma | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06977581) |
| April 23, 2025 | NCT06940700 | Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma | Guangdong Hengrui Pharmaceutical Co., Ltd | Phase 2 | Not yet recruiting | Asthma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06940700) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Colorado, Denver | 3 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 2 |
| Anhui Palo Alto Pharmaceuticals, Inc. | 2 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 1 |
| Phoenix Children's Hospital | 1 |
| Indiana University | 1 |
| [Akeso](https://specstream.ai/data/clinical-trials/company/akeso) | 1 |
| The Hospital for Sick Children | 1 |
| Foresee Pharmaceuticals Co., Ltd. | 1 |
| Kinaset Therapeutics Inc | 1 |
| National Jewish Health | 1 |
| [Keymed Biosciences Co.Ltd](https://specstream.ai/data/clinical-trials/company/keymed-biosciences-co-ltd) | 1 |
| Johns Hopkins All Children's Hospital | 1 |
| [Guangdong Hengrui Pharmaceutical Co., Ltd](https://specstream.ai/data/clinical-trials/company/guangdong-hengrui-pharmaceutical-co-ltd) | 1 |
| Connect Biopharm LLC | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| Shanghai Novamab Biopharmaceuticals Co., Ltd. | 1 |
| The University of Texas Medical Branch, Galveston | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Sultan Qaboos University | 1 |
| Enveda Therapeutics | 1 |
| Region Skane | 1 |
| Mayo Clinic | 1 |
| Johns Hopkins University | 1 |
| University of Alabama at Birmingham | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| China | 10 |
| Argentina | 7 |
| Hungary | 5 |
| Poland | 5 |
| Bulgaria | 4 |
| Germany | 4 |
| South Africa | 4 |
| Japan | 4 |
| Spain | 4 |
| Czechia | 3 |
| Mexico | 3 |
| Serbia | 3 |
| United Kingdom | 3 |
| France | 3 |
| Canada | 3 |
| Brazil | 2 |
| India | 2 |
| Israel | 2 |
| Italy | 2 |
| South Korea | 2 |
| Taiwan | 2 |
| Sweden | 2 |
| Oman | 2 |
| Bosnia and Herzegovina | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Insurance agencies in the United States](https://specstream.ai/data/businesses/insurance-agencies/united-states)
- [Avionics shops in the United States](https://specstream.ai/data/businesses/avionics-shops/united-states)
- [Mexican restaurants in the United States](https://specstream.ai/data/businesses/mexican-restaurants/united-states)
- [Business management services in the United States](https://specstream.ai/data/businesses/business-management-services/united-states)
- [Playground equipment suppliers in the United States](https://specstream.ai/data/businesses/playground-equipment-suppliers/united-states)
- [Dental supply stores in the United States](https://specstream.ai/data/businesses/dental-supply-stores/united-states)
